- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03711487
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection
September 14, 2019 updated by: Ziqiang Wang,MD, West China Hospital
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection: a Randomized Controlled Trial.
Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote bowel function recovery, but the efficacy of ironing therapy remains uncertain after colorectal resection surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Postoperative ileus is one of the most common complications after abdominal surgery.
It refers to obstipation and intolerance of oral intake due to nonmechanical factors that disrupt the normal coordinated propulsive motor activity of the gastrointestinal tract following abdominal or nonabdominal surgery.
When the expected period of gastrointestinal recovery time extends beyond what is acceptable, the patient is diagnosed as having a "pathologic" postoperative ileus (POI), which leads to patient discomfort, dissatisfaction, prolonged hospitalization and increased medical expenses.
The incidence of POI is about 17%~24% after abdominal surgery.
Chinese Medicine Ironing using Foeniculum vulgare has been applied in some departments to promote gastrointestinal function recovery as a empiric therapy.
However, the definite efficacy of Foeniculum vulgare ironing therapy(FIT)is uncertain after colorectal resection surgery and whether FIT can reduce the incidence of POI remains unkonown.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- Guoxue Road 37#,West China Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 18 ~ 85 years old; sex is not limited.
- Selective operation of colorectal partial resection.
- Participants are volunteered to participate in this study, sign informed consent, and cooperated with follow-up.
Exclusion Criteria:
- Emergency surgery.
- Pregnant or lactating women.
- ASA class 4 or 5 patients.
- Patients with severe abdominal adhesions, which would cost more than 30 minutes to release. Patients with abdominal cocoon disease.
- Patients with peritoneal metastasis or inflammatory bowel disease.
- Patients undergoing enterostomy or total colectomy.
- Patients simultaneously enrolled in any other competing clinical study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No intervention
No intervention.
|
|
Experimental: Ironing therapy
Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows.
Put them into a cotton bag.
Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, 4 times daily from 12 hours after surgery and last for 2 days.
The medicine bag can be heated and reused after it cool down.
|
Stir-fry 500 grams of Foeniculum vulgare seeds until the aroma overflows.
Put them into a cotton bag.
Ironing therapy put the bag on abdomen after the temperature is suitable, 30 minutes per time, twice daily on postoperative days 2 to 3. The medicine bag can be heated and reused after it cool down.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flatus time
Time Frame: Up to 30 days after operation.
|
Time to faltus (hours from end of operation).
Patients who had stool before any movement of gas were deemed to have an equal time to the time to flatus and first bowel movement.
|
Up to 30 days after operation.
|
Incidence of postoperative ileus
Time Frame: 4 days after operation
|
The same panel defined "prolonged" postoperative ileus as the occurrence of two or more of the following signs and symptoms on postoperative day 4 or after: Nausea or vomiting, Inability to tolerate an oral diet over the preceding 24 hours, Absence of flatus over the preceding 24 hours, Abdominal distention.
|
4 days after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Toleration of a low-residue diet
Time Frame: Up to 30 days after operation.
|
Time (hours from end of operation) to tolerate a low-residue diet, defined as consuming >50% of the meal without emesis for 24 hours (time recorded was the time when the patient ate >50% of the meal).
|
Up to 30 days after operation.
|
Toleration of drinking water
Time Frame: Up to 30 days after operation.
|
Time (hours from end of operation) to toleration of water.
|
Up to 30 days after operation.
|
Duration of postoperative hospitalization
Time Frame: Up to 30 days after operation.
|
Postoperative days the patient was ready for hospital discharge based on Gastrointestinal function alone.
|
Up to 30 days after operation.
|
Pain assessment
Time Frame: During postoperative hospitalization, up to 30 days after operation.
|
Assess postoperative pain with the pain visual analogue scale.
Rate the pain levels on a likert scale from 0 (no pain) to 10 (pain as bad as it could possibly be).
|
During postoperative hospitalization, up to 30 days after operation.
|
Nausea and appetite assessment
Time Frame: During postoperative hospitalization, up to 30 days after operation.
|
Rate their appetite and nausea levels on a likert scale from 0 (no appetite, nausea) to 10 (appetite as good as can be, nausea as bad as can be), and each score was recorded separately.
|
During postoperative hospitalization, up to 30 days after operation.
|
Short-term complications
Time Frame: Up to 30 days after operation.
|
Complications during the 30-day postoperative period
|
Up to 30 days after operation.
|
Adverse events
Time Frame: Up to 30 days after operation.
|
Any adverse events possibly related to treatment with Foeniculum vulgare ironing.
|
Up to 30 days after operation.
|
Hospitalization costs
Time Frame: During postoperative hospitalization, up to 30 days after operation.
|
Postoperative in-patients costs
|
During postoperative hospitalization, up to 30 days after operation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ziqiang Wang, MD, West China Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Choi EM, Hwang JK. Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia. 2004 Sep;75(6):557-65. doi: 10.1016/j.fitote.2004.05.005.
- Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm. 2009 Jul-Aug;15(6):485-94. doi: 10.18553/jmcp.2009.15.6.485.
- Ma HW, Zhao JT, Zhao X. [The Effect of Fennel Tea Drinking on Postoperative Gut Recovery after Gynecological Malignancies Operation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Nov;46(6):940-3. Chinese.
- Miguel MG, Cruz C, Faleiro L, Simoes MT, Figueiredo AC, Barroso JG, Pedro LG. Foeniculum vulgare essential oils: chemical composition, antioxidant and antimicrobial activities. Nat Prod Commun. 2010 Feb;5(2):319-28.
- Rezayat SM, Dehpour AR, Motamed SM, Yazdanparast M, Chamanara M, Sahebgharani M, Rashidian A. Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacology. 2018 Jun;26(3):851-859. doi: 10.1007/s10787-017-0409-1. Epub 2017 Oct 24.
- Jang SH, Yang DK. The combination of Cassia obtusifolia L. and Foeniculum vulgare M. exhibits a laxative effect on loperamide-induced constipation of rats. PLoS One. 2018 Apr 5;13(4):e0195624. doi: 10.1371/journal.pone.0195624. eCollection 2018. Erratum In: PLoS One. 2018 Aug 9;13(8):e0202259.
- Mattei P, Rombeau JL. Review of the pathophysiology and management of postoperative ileus. World J Surg. 2006 Aug;30(8):1382-91. doi: 10.1007/s00268-005-0613-9.
- Bragg D, El-Sharkawy AM, Psaltis E, Maxwell-Armstrong CA, Lobo DN. Postoperative ileus: Recent developments in pathophysiology and management. Clin Nutr. 2015 Jun;34(3):367-76. doi: 10.1016/j.clnu.2015.01.016. Epub 2015 Jan 31.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2018
Primary Completion (Actual)
June 15, 2019
Study Completion (Actual)
July 15, 2019
Study Registration Dates
First Submitted
October 12, 2018
First Submitted That Met QC Criteria
October 17, 2018
First Posted (Actual)
October 18, 2018
Study Record Updates
Last Update Posted (Actual)
September 17, 2019
Last Update Submitted That Met QC Criteria
September 14, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FV-GIR-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Surgery
-
Medical University of South CarolinaCompletedColorectal Surgery | Hepatobiliary SurgeryUnited States
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
York Teaching Hospitals NHS Foundation TrustCompletedColorectal Surgery | Major Abdominal SurgeryUnited Kingdom
-
IHU StrasbourgRecruitingColorectal SurgeryFrance
-
Indiana UniversityCompletedColorectal SurgeryUnited States
-
Wake Forest University Health SciencesWithdrawnColorectal Surgery
-
University of Massachusetts, WorcesterCompleted
-
Helsinki University Central HospitalActive, not recruiting
-
Children's Hospital Medical Center, CincinnatiTerminated
-
York Teaching Hospitals NHS Foundation TrustTerminatedColorectal SurgeryUnited Kingdom
Clinical Trials on Foeniculum Vulgare Seed Ironing
-
Pusan National University Yangsan HospitalCompletedChronic ConstipationKorea, Republic of
-
University of KarachiAltamash Institute of Dental MedicineCompletedSaliva Altered | Electrolyte DisturbancePakistan